The medical field is witnessing a major shift in diabetes care with the arrival of GLP-1 transdermal devices. These groundbreaking methods offer a likely simple alternative to subcutaneous injections for individuals managing diabetes. By circumventing the need for frequent injections, GLP-1 patch